Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (291-300 of 597) with videos related to

Pageof 60
Sort By:
Haematologica|June 13, 2003
Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrowWolfgang Kern, Susanne Danhauser-Riedl, Richard Ratei, et al.
Cytometry. Part B, Clinical Cytometry|September 2, 2003
Correlation of protein expression and gene expression in acute leukemiaWolfgang Kern, Alexander Kohlmann, Christian Wuchter, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2011
Strategy for robust detection of insertions, deletions, and point mutations in CEBPA, a GC-rich content gene, using 454 next-generation deep-sequencing technologyVera Grossmann, Susanne Schnittger, Sonja Schindela, et al.
British Journal of Haematology|March 29, 2002
Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo-1) and Fas ligand (CD178) expressionHelmut R Salih, Gary C Starling, Stephan F Brandl, et al.
Haematologica|August 22, 2015
Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemiaManja Meggendorfer, Andreia de Albuquerque, Niroshan Nadarajah, et al.
Blood|October 24, 2002
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 TrialWolfgang Kern, Torsten Haferlach, Claudia Schoch, et al.
Leukemia & Lymphoma|March 17, 2012
Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemiaEnrica Bach, Rainer Krahl, Thoralf Lange, et al.
Seminars in Cancer Biology|July 13, 2021
Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncologyVaidehi Jobanputra, Kazimierz O Wrzeszczynski, Reinhard Buttner, et al.
Journal of Clinical Laboratory Analysis|June 8, 2026
Not Missing the Notch: Detection Challenges of Juxtamembrane NOTCH1 Variant Detection in T-Cell Acute Lymphoblastic LeukemiaFrancisco Beas, Stephan Hutter, Ferran Balbastre-Úbeda, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|December 1, 2004
XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosisIngo Tamm, Stephan Richter, Frank Scholz, et al.
Pageof 60

Showing results (291-300 of 597) with videos related to

Sort By:
Pageof 60
Haematologica|June 13, 2003
Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrowWolfgang Kern, Susanne Danhauser-Riedl, Richard Ratei, et al.
Cytometry. Part B, Clinical Cytometry|September 2, 2003
Correlation of protein expression and gene expression in acute leukemiaWolfgang Kern, Alexander Kohlmann, Christian Wuchter, et al.
The Journal of Molecular Diagnostics : JMD|March 1, 2011
Strategy for robust detection of insertions, deletions, and point mutations in CEBPA, a GC-rich content gene, using 454 next-generation deep-sequencing technologyVera Grossmann, Susanne Schnittger, Sonja Schindela, et al.
British Journal of Haematology|March 29, 2002
Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo-1) and Fas ligand (CD178) expressionHelmut R Salih, Gary C Starling, Stephan F Brandl, et al.
Haematologica|August 22, 2015
Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemiaManja Meggendorfer, Andreia de Albuquerque, Niroshan Nadarajah, et al.
Blood|October 24, 2002
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 TrialWolfgang Kern, Torsten Haferlach, Claudia Schoch, et al.
Leukemia & Lymphoma|March 17, 2012
Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemiaEnrica Bach, Rainer Krahl, Thoralf Lange, et al.
Seminars in Cancer Biology|July 13, 2021
Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncologyVaidehi Jobanputra, Kazimierz O Wrzeszczynski, Reinhard Buttner, et al.
Journal of Clinical Laboratory Analysis|June 8, 2026
Not Missing the Notch: Detection Challenges of Juxtamembrane NOTCH1 Variant Detection in T-Cell Acute Lymphoblastic LeukemiaFrancisco Beas, Stephan Hutter, Ferran Balbastre-Úbeda, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|December 1, 2004
XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosisIngo Tamm, Stephan Richter, Frank Scholz, et al.
Pageof 60